Tofacitinib, an oral Janus kinase inhibitor, in the treatment of ulcerative colitis: an interim analysis of an open-label, long-term extension study with up to 5.5 years of treatment

Gary R. Lichtenstein  1     Edward V. Loftus Jr.  2     Arif Soonasra  3     Nervin Lawendy  3     Gary Chan  3     Haiying Zhang     Wenjin Wang     Andrew J. Thorpe     Stuart Bloom    
1 Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania,Philadelphia, PA,United States
2 Division of Gastroenterology and Hepatology, Mayo Clinic,Rochester, MN,United States
3 Pfizer Inc,Collegeville, PA,United States

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing